Stay updated with breaking news from Leinco Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global ... | March 29, 2022
Learn how antibody researchers teamed up with a biologics manufacturer to develop diagnostic tests and treatments for viral infections
Learn how antibody researchers teamed up with a biologics manufacturer to develop diagnostic tests and treatments for viral infections
Abstract The compelling need to provide adoptive cell therapy (ACT) to an increasing number of oncology patients within a meaningful therapeutic window makes the development of an efficient, fast, versatile, and safe genetic tool for creating recombinant T cells indispensable. In this study, we used nonintegrating minimally sized DNA vectors with an enhanced capability of generating genetically modified cells, and we demonstrate that they can be efficiently used to engineer human T lymphocytes. This vector platform contains no viral components and is capable of replicating extrachromosomally ...
Special Feature: 10 top new resources to advance your engineered antibody research Explore our exclusive interviews, free downloads, latest methods, and much more to help support your antibody research 16 Mar 2021 As part of our new special feature, we’ve pulled together a selection of the top new resources to aid your work with engineered antibodies. Download our comprehensive guide to optimal antibody selection and application, discover the value of label-free technology for streamlined drug discovery workflows, explore the development of next-generation antibodies, and much more. Transfo...